A placebo controlled study of the effect of extended treatment with rituximab on resistant rheumatoid arthritis: Clinical and radiological outcomes

Trial Profile

A placebo controlled study of the effect of extended treatment with rituximab on resistant rheumatoid arthritis: Clinical and radiological outcomes

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jan 2014

At a glance

  • Drugs Rituximab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms EXTRRA
  • Most Recent Events

    • 04 Sep 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 16 Jun 2010 Results have been presented at the 11th Annual Congress of the European League Against Rheumatism.
    • 14 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top